Encyclopedia of Clinical Neuropsychology

2018 Edition
| Editors: Jeffrey S. Kreutzer, John DeLuca, Bruce Caplan

Glioblastoma Multiforme

  • Jacqueline L. CunninghamEmail author
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-57111-9_111




The glioblastoma multiforme (GBM) is a tumor of the central nervous system and is the most common adult brain tumor. It is a rapidly growing glioma, which is invasive, structurally undifferentiated (anaplastic), and undergoing mitotic division. It is graded at levels III or IV to indicate high malignancy. GBM may occur anywhere in the central nervous system. It accounts for about 15–20% of all intracranial tumors, 55% of all gliomas, and 90% of all cerebral gliomas (Fig. 1).
This is a preview of subscription content, log in to check access.


  1. Ene, C. I., & Holland, E. C. (2015). Personalized medicine for gliomas. Surgical Neurology International, 6(Suppl. 1), S89–S95.PubMedPubMedCentralGoogle Scholar
  2. Schiff, D., & Wen, P. Y. (2003). Cancer neurology in clinical practice. New York: Humana Press.CrossRefGoogle Scholar
  3. Stupp, R., Mason, W. P., & van den Bent, M. J. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 352, 987–996.CrossRefGoogle Scholar
  4. Wagle, N., Nghiemphu, L., Lai, A., Pope, W., Mischel, P. S., & Cloughesy, T. (2010). Update and developments in the treatment of glioblastoma multiforme – Focus on bevacizumab. Pharmgenomics and Personalized Medicine, 3, 79–85.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of PsychologyChildren’s Hospital of PhiladelphiaPhiladelphiaUSA